Neo Ivy Capital Management Insmed Inc Transaction History
Neo Ivy Capital Management
- $293 Million
- Q1 2025
A detailed history of Neo Ivy Capital Management transactions in Insmed Inc stock. As of the latest transaction made, Neo Ivy Capital Management holds 4,452 shares of INSM stock, worth $448,049. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,452Holding current value
$448,049% of portfolio
0.12%Shares
11 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.84 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.55 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.44 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$1.3 Billion0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$724 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $13.6B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...